Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development — Zhaoxiang Bian (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development
Shared by
David Moher
Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development
Article
2011
en
Authors
+4 more
ZB
Zhaoxiang Bian
BL
Baoyan Liu
David Moher
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2007
Consolidated Standards for Reporting Trials of Traditional Chinese Medicine (CONSORT for TCM) (For Solicitation of Comments)
Taixiang Wu
,
Youping Li
,
Zhaoxiang Bian
,
Ting-qian Li
,
Jing Li
,
Simon Dagenais
,
David Moher
Article
2010
Consolidated Standards of Reporting Trials Group. CONSORT 2010 explanation and elaboration : updated guidelines for reporting parallel group randomized trials
David Moher
Article
2007
中医药临床随机对照试验报告规范(征求意见稿) = Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM)
Taixiang Wu
,
Youping Li
,
Zhaoxiang Bian
,
Ting-qian Li
,
Simon Dagenais
,
David Moher
Article
2012
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals
Lucy Turner
,
Larissa Shamseer
,
Douglas G. Altman
,
Laura Weeks
,
Jodi Peters
,
Thilo Kober
,
Sofia Dias
,
Kenneth F. Schulz
,
Amy C. Plint
,
David Moher
Article
2017
CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version)
Chung Wah Cheng
,
Taixiang Wu
,
Hongcai Shang
,
Youping Li
,
Douglas G. Altman
,
David Moher
,
Zhaoxiang Bian
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.